Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
A 3.5 angstrom resolution electron density map of the HIV-1 reverse transcriptase heterodimer complexed with nevirapine, a drug with potential for treatment of AIDS, reveals an asymmetric dimer. The polymerase (pol) domain of the 66-kilodalton subunit has a large cleft analogous to that of the Klenow fragment of Escherichia coli DNA polymerase I. However, the 51-kilodalton subunit of identical sequence has no such cleft because the four subdomains of the pol domain occupy completely different relative positions. Two of the four pol subdomains appear to be structurally related to subdomains of the Klenow fragment, including one containing the catalytic site. The subdomain that appears likely to bind the template strand at the pol active site has a different structure in the two polymerases. Duplex A-form RNA-DNA hybrid can be model-built into the cleft that runs between the ribonuclease H and pol active sites. Nevirapine is almost completely buried in a pocket near but not overlapping with the pol active site. Residues whose mutation results in drug resistance have been approximately located.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the connection domain lacks any catalytic site and has α–helices on only one side of the β–sheet (Figure 2a), compared to the RNH and IN domains (Figure 2b and 2c, respectively) [14].”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [14]
In the citing paper
“The mature, functional form of HIV-1 RT is a heterodimer, comprising 66 kDa and 51 kDa subunits (Figure 1b)”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [14]
In the citing paper
“the connection domain directly interacts with nucleic acids via positively charged side chains to help heterodimer formation and possibly position the substrate in the RNH active site [14,15].”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [14]
Citations
Cites
Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.
Poch, O., Sauvaget, I., Delarue, M., & Tordo, N. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08565.x · Cited by 1,202
Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
Larder, B. A., & Kemp, S. D. (1989) · Science · doi:10.1126/science.2479983 · Cited by 1,163
Beese, L. S., & Steitz, T. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07917.x · Cited by 1,048
Self-citationResolution of phase ambiguity in macromolecular crystallography
Wang, B.-C. (1985) · Methods in Enzymology · doi:10.1016/0076-6879(85)15009-3 · Cited by 1,028
The accuracy of reverse transcriptase from HIV-1
Roberts, J. D., Bebenek, K., & Kunkel, T. A. (1988) · Science · doi:10.1126/science.2460925 · Cited by 997
Fidelity of HIV-1 reverse transcriptase
Preston, B. D., Poiesz, B. J., & Loeb, L. A. (1988) · Science · doi:10.1126/science.2460924 · Cited by 931
Structure of large fragment of Escherichia coli DNA polymerase I complexed with dTMP
Ollis, D. L., Brick, P., Hamlin, R., Xuong, N. G., & Steitz, T. A. (1985) · Nature · doi:10.1038/313762a0 · Cited by 848
Self-citationWeiss, R. A., & Bernstein, A. (1982) · Cold Spring Harbor Laboratory eBooks · Cited by 828
Carson, M. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891007240 · Cited by 808
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M. J., Breslin, H. J., Raeymaeckers, A., Gelder, J. V., Woestenborghs, R., Heykants, J., et al. (1990) · Nature · doi:10.1038/343470a0 · Cited by 756
Research works printed but not linked: 2
- Kohlstaedt, L. A., Proceedings of the National Academy of Sciences of the United States of America 89: 9652 (1992).
- VARMUS, H, REVERSE TRANSCRIPTION, SCIENTIFIC AMERICAN 257: 56 (1987).
Cited by
Items 601–700 of 1,005
Reverse transcriptase incorporation of 1,5-anhydrohexitol nucleotides
Vastmans, K., Froeyen, M., Kerremans, L., Pochet, S., & Herdewijn, P. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.15.3154 · Cited by 79
Shwed, P. S., Dobos, P., Cameron, L. A., Vakharia, V. N., & Duncan, R. (2002) · Virology · doi:10.1006/viro.2001.1334 · Cited by 54
Sevilya, Z., Loya, S., Hughes, S. H., & Hizi, A. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4904 · Cited by 58
DNA Polymerase and Mammalian Base Excision Repair
WILSON, S. H., SOBOL, R. W., BEARD, W. A., HORTON, J. K., PRASAD, R., & VANDE BERG, B. J. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.143 · Cited by 54
Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review
Tarasova, O. A., Poroikov, V., & Veselovsky, A. V. (2018) · Molecules · doi:10.3390/molecules23051233 · Cited by 55
“The hydrophobic pocket of allosteric site contains the amino acid residues: L100, K101, K103, V106, T107, V108, V179, Y181, Y188, V189, G190, F227, W229, L234, Y318 of p66 and E138 of p51 [42,43].”
Abram, M. E., & Parniak, M. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.11952-11961.2005 · Cited by 53
“Numerous crystal structures of the RT p66/p51 heterodimer show that the 7-amino-acid p51RNH cleavage sequence in the p66 subunit is buried (37, 46, 76) and therefore presumably inaccessible to PR.”
BackgroundHe, X. D., Mei, Y., Xiang, Y., Zhang, D. W., & Zhang, J. Z. H. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20578 · Cited by 53
Kubis, S. E., Heslop-Harrison, J. S., Desel, C., & Schmidt, T. (1998) · Plant Molecular Biology · doi:10.1023/a:1005973932556 · Cited by 65
“The three-dimensional structure of the reverse transcriptase from HIV-1 retrovirus has been determined by X-ray crystal analysis [17].”
MethodInhibitors of HIV- I reverse transcriptase
Parniak, M. A., & Sluis‐Cremer, N. (2000) · Advances in pharmacology · doi:10.1016/s1054-3589(00)49024-1 · Cited by 62
Selmi, B., Deval, J., Alvarez, K., Boretto, J., Sarfati, S. R., Guerreiro, C., & Canard, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302928200 · Cited by 52
Eckert, K. A., & Kunkel, T. A. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.22.5212 · Cited by 52
Smallwood, S. E., Easson, C., Feller, J. A., Horikami, S. M., & Moyer, S. A. (1999) · Virology · doi:10.1006/viro.1999.9933 · Cited by 58
Clinical Utility of Current NNRTIs and Perspectives of New Agents in This Class under Development
Zhang, Z., Hamatake, R. K., & Hong, Z. (2004) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020401500302 · Cited by 53
“This pocket is composed of amino acid residues 98–110 and 179–190 (Kohlstaedt et al., 1992).”
BackgroundDrosopoulos, W. C., & Prasad, V. R. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4834-4838.1996 · Cited by 61
“Insights into the molecular basis of the decreased susceptibility of the E89G variant of HIV-1 RT to nucleoside analogs have come from biochemical studies of recombinant mutant enzymes (6, 15, 37) and X-ray structural information about the wild-type enzyme (6, 13, 16).”
BackgroundNajmudin, S., Coté, M. L., Sun, D., Yohannan, S., Montaño, S. P., Gu, J., & Georgiadis, M. M. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3477 · Cited by 55
Kensch, O., Restle, T., Wöhrl, B. M., Goody, R. S., & Steinhoff, H. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3998 · Cited by 59
Keck, J. L., & Marqusee, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2740 · Cited by 52
Chen, Y., Robinson, W. S., & Marion, P. L. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5232-5238.1994 · Cited by 52
“Even if template binding by the RNase H domain is not required in initiation of DNA synthesis or in packaging, this domain may be an essential part of the conformation of active DNA polymerase engaged on the template, similar to the conformational activation of RNase H by the RT domain of the HIVpol gene product (14).”
BackgroundClustENM: ENM-Based Sampling of Essential Conformational Space at Full Atomic Resolution
Kurkcuoglu, Z., Bahar, İ., & Doruker, P. (2016) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.6b00319 · Cited by 57
Structure of HIV-1 reverse transcriptase cleaving RNA in an RNA/DNA hybrid
Tian, L., Kim, M.-S., Li, H., Wang, J., & Yang, W. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719746115 · Cited by 51
“Its two subunits, p51 and p66, share the same coding sequence but have different tertiary structures (2, 5, 7).”
BackgroundSelf-citationFijalkowska, I. J., & Schaaper, R. M. (1993) · Genetics · doi:10.1093/genetics/134.4.1039 · Cited by 52
Mao, C., Sudbeck, E. A., Venkatachalam, T. K., & Uckun, F. M. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00235-8 · Cited by 52
Prophylactic contraceptives for HIV/AIDS
Uckun, F. M. (1999) · Human Reproduction Update · doi:10.1093/humupd/5.5.506 · Cited by 52
Might the M184V substitution in HIV-1 RT confer clinical benefit?
Petrella, M., & Wainberg, M. A. (2002) · PubMed · Cited by 51
Mugnaini, C., Alongi, M., Togninelli, A., Gevariya, H., Brizzi, A., Manetti, F., Bernardini, C., Angeli, L., Tafi, A., Bellucci, L., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0708230 · Cited by 52
Yasukawa, K., Mizuno, M., Konishi, A., & Inouye, K. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.09.961 · Cited by 51
Effects of Poliovirus 3AB Protein on 3D Polymerase-catalyzed Reaction
Richards, O. C., & Ehrenfeld, E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12832 · Cited by 51
Retroviral recombination: what drives the switch?
Negroni, M., & BUC, H. C. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052098 · Cited by 58
TAUBE, R., LOYA, S., AVIDAN, O., PERACH, M., & HIZI, A. (1998) · Biochemical Journal · doi:10.1042/bj3290579 · Cited by 51
NMR assignments and solution conformation of the DNA · RNA hybrid duplex d(GTGAACTT) · r(AAGUUCAC)
Lane, A. N., Ebel, S., & Brown, T. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18035.x · Cited by 51
Kelly, T. A., McNeil, D. W., Rose, J. M., David, E., Shih, C.-K., & Grob, P. M. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960837y · Cited by 51
The Conserved Active Site Motif A of Escherichia coliDNA Polymerase I Is Highly Mutable
Shinkai, A., Patel, P. H., & Loeb, L. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011472200 · Cited by 50
Nuclease footprinting of human immunodeficiency virus reverse transcriptase/tRNA(Lys-3) complexes
Wöhrl, B. M., Ehresmann, B., Keith, G., & Le Grice, S. F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38693-4 · Cited by 51
Deng, B., Hartman, T. L., Robert W. Buckheit, Pannecouque, C. C., Clercq, E. D., & Cushman, M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060449o · Cited by 55
Mutational Analysis of Tyr-501 of HIV-1 Reverse Transcriptase
Arion, D., Sluis-Cremer, N., Min, K.-L., Abram, M. E., Fletcher, R. S., & Parniak, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110254200 · Cited by 50
Ren, J., & STAMMERS, D. K. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.11.003 · Cited by 50
Yin, P. D., Das, D., & Mitsuya, H. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6009-7 · Cited by 53
Sudbeck, E. A., Mao, C., Vig, R., Venkatachalam, T. K., Tuel-ahlgren, L., & Uckun, F. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3225 · Cited by 50
“The nonnucleoside inhibitor (NNI) binding site of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) has been studied extensively (20, 21, 29, 32, 40, 41, 44, 46).”
BackgroundFidelity of hepatitis B virus polymerase
Park, S., Kim, Y., Park, E., Ryu, H. M., & Jung, G. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03650.x · Cited by 66
“As RT is a preferred target for the development of viral inhibitors as antiviral drugs, researches have focused on the structural and catalytic properties of RTs, including three-dimensional crystal studies [16–18].”
BackgroundRole of lipid rafts in virus assembly and budding
Nayak, D. P., & Barman, S. (2002) · Advances in virus research · doi:10.1016/s0065-3527(02)58001-5 · Cited by 54
Martín‐Hernández, A. M., Gutiérrez-Rivas, M., Domingo, E., & Menéndez-Arias, L. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.7.1383 · Cited by 53
Aspects of successful drug discovery and development
Pauwels, R. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.05.007 · Cited by 50
O’Reilly, M., Teichmann, S. A., & Rhodes, D. (1999) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)80008-6 · Cited by 63
Ghosh, M. P., Howard, K. J., Cameron, C. E., Benkovic, S. J., Hughes, S. H., & Grice, S. F. J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7068 · Cited by 53
Ye, F. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.8.1481 · Cited by 50
Lansdon, E. B., Samuel, D., Lagpacan, L., Brendza, K. M., White, K. L., Hung, M., Liu, X., Boojamra, C. G., Mackman, R. L., Cihlar, T., et al. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.02.019 · Cited by 49
Domaoal, R. A., & Demeter, L. M. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.02.026 · Cited by 54
Gupta, S., Fransen, S., Paxinos, E. E., Stawiski, E. W., Huang, W., & Petropoulos, C. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00870-09 · Cited by 54
“In contrast, NNRTIs act noncompetitively by binding to a hydrophobic pocket adjacent to, but distinct from, the polymerase active site and mediating allosteric changes that inhibit RT activity (14, 31, 35).”
BackgroundDufour, E., Méndez, J., Lázaro, J. M., de Vega, M., Blanco, L., & Salas, M. A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4216 · Cited by 49
Mutants of T7 RNA polymerase that are able to synthesize both RNA and DNA
Kostyuk, D. A., Dragan, S. M., Lyakhov, D. L., Rechinsky, V. O., Tunitskaya, V. L., CHERNOV, B. K., & Kochetkov, S. N. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00732-o · Cited by 49
Voorman, R. L., Maio, S. M., Hauer, M. J., Sanders, P. E., Payne, N. A., & Ackland, M. J. (1998) · PubMed · Cited by 52
HARUKI, M., NOGUCHI, E., NAKAI, C., LIU, Y., OOBATAKE, M., ITAYA, M., & KANAYA, S. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18664.x · Cited by 49
Bakhanashvili, M., Avidan, O., & Hizi, A. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00747-8 · Cited by 55
Ligand-induced formation of nucleic acid triple helices.
Pilch, D. S., & Breslauer, K. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9332 · Cited by 49
Hussain, M., & Lok, A. S.-F. (1999) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1999.00160.x · Cited by 54
Site Size of Cooperative Single-stranded RNA Binding by Poliovirus RNA-dependent RNA Polymerase
Beckman, M. T. L., & Kirkegaard, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.6724 · Cited by 49
Beard, W. A., Minnick, D. T., Wade, C. L., Prasad, R., Won, R. L., Kumar, A., Kunkel, T. A., & Wilson, S. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12213 · Cited by 49
Sluis‐Cremer, N., & Tachedjian, G. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03216.x · Cited by 49
Chang, G. S., Hong, Y., Ko, K. D., Bhardwaj, G., Holmes, E. C., Patterson, R. L., & van Rossum, D. B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803860105 · Cited by 57
“Within the highly divergent RT domain, seven conserved motifs in the catalytic region of the enzyme have been identified that enable phylogenetic inferences of retrotransposons (23, 27, 29, 30).”
BackgroundUnveiling the Roles of HBV Polymerase for New Antiviral Strategies
Clark, D. N., & Hu, J. (2015) · Future Virology · doi:10.2217/fvl.14.113 · Cited by 59
Quantum study of mutational effect in binding of efavirenz to HIV‐1 RT
Mei, Y., He, X. D., Xiang, Y., Zhang, D. W., & Zhang, J. Z. H. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20455 · Cited by 48
Huang, L., Ishii, K. K., Zuccola, H. J., Gehring, A. M., Hwang, C. B. C., Hogle, J. M., & Coen, D. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.447 · Cited by 48
Ranjith-Kumar, C. T., Gutshall, L., Sarisky, R. T., & Kao, C. C. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00613-2 · Cited by 48
Allosteric Suppression of HIV-1 Reverse Transcriptase Structural Dynamics upon Inhibitor Binding
Seckler, J. M., Barkley, M. D., & Wintrode, P. L. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2010.11.004 · Cited by 57
Prevalence and evolution of drug resistance HIV-1 variants in Henan, China
Li, J. Y., Han Ping, L. I., Li, L., Li, H., Wang, Z., Yang, K., Bao, Z., Zhuang, D., Si Yang, L. I. U., Yong Jian, L. I. U., et al. (2005) · Cell Research · doi:10.1038/sj.cr.7290356 · Cited by 48
Lewis, P. J., de Jonge, M. R., Daeyaert, F. F. D., Koymans, L. M. H., Vinkers, M. H., Heeres, J., Janssen, P. A. J., Arnold, E., Das, K., Clark, A. D., et al. (2003) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1025313705564 · Cited by 51
Kopka, M. L., Lavelle, L., Han, G. W., Ng, H. L., & Dickerson, R. E. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.09.057 · Cited by 52
He, Y., Chen, F., Sun, G., Wang, Y., Clercq, E. D., Balzarini, J. M., & Pannecouque, C. C. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.04.008 · Cited by 48
An Expanding View of Aminoglycoside–Nucleic Acid Recognition
Willis, B., & Arya, D. P. (2006) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/s0065-2318(06)60006-1 · Cited by 53
“—DNA/RNA hybrid duplexes are biologically relevant due to their recognition by such enzymes as RNase H and reverse transcriptase.(189,190) Recognition of such structures by small molecules therefore has potential in antiviral applications.”
BackgroundShimamoto, T., Hsu, M.-Y., Inouye, S., & Inouye, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53828-x · Cited by 48
Reha-Krantz, L. J., Nonay, R. L., & Stocki, S. (1993) · Journal of Virology · doi:10.1128/jvi.67.1.60-66.1993 · Cited by 48
“coli Klenow fragment and human immunodeficiency virus type 1 reverse transcriptase show that both enzymes have a prominent cleft with multiple potential protein-DNA interaction sites (25, 36).”
BackgroundZhang, H., Dornadula, G., Wu, Y., Havlir, D. V., Richman, D. D., & Pomerantz, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.628-634.1996 · Cited by 48
“Only after the mature RT enzyme is released by the HIV-1 protease from its precursor, during or after virion budding, could nevirapine bind to the hydrophobic pocket structure formed in the mature p66/ p51 heteroduplex dimer of HIV-1 RT (12).”
BackgroundReverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription
Warren, K., Warrilow, D., Meredith, L. W., & Harrich, D. (2009) · Viruses · doi:10.3390/v1030873 · Cited by 62
“and a 440-amino-acid 51-kDa subunit (p51) [1] (Figure 1).”
BackgroundThe mechanism of splicing as told by group II introns: Ancestors of the spliceosome
Smathers, C. M., & Robart, A. R. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.06.001 · Cited by 49
Iglesias-Ussel, M. D., Casado, C., Yuste, E., Olivares, I., & López‐Galíndez, C. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-1-93 · Cited by 57
“The loss of antiviral activity is associated with the acquisition of several mutations around the hydrophobic catalytic pocket in the p66 subunit of the RT, mainly at amino acid positions 103 (K!N), 106 (V!A), 181 (Y!C}I), 188 (Y!C) and 190 (G!A) (Kohlstaedt et al., 1992 ; Korber et al., 1998 ; Smerdon et al., 1994).”
Yang, L., Beard, W. A., Wilson, S. H., Broyde, S. B., & Tamar Schlick, A. (2004) · Biophysical Journal · doi:10.1529/biophysj.103.036012 · Cited by 47
“…Asp411 Asp621* Asp623 Wang et al. (1997) P2 DNA polymerase IV (Dpo4) Asp7 Asp105 Glu106 Ling et al., 2001 HIV RT Asp110 Asp185 Asp186* Huang et al. (1998); Kohlstaedt et al. (1992); Larder et al. (1987, 1989) *The underlined residues are not absolutely conserved and are variable in the polymerase.”
BackgroundPontikis, R., Dollé, V., Guillaumel, J., Dechaux, E., Note, R., Nguyen, C. H., Legraverend, M., Bisagni, É., Aubertin, A.-M., Grierson, D. S., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm991125l · Cited by 47
Weißhart, K., Kuo, A. A., Hwang, C. B. C., Kumura, K., & Coen, D. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31714-3 · Cited by 49
Powell, M. D., Beard, W. A., Bebenek, K., Howard, K. J., Le Grice, S. F. J., Darden, T. A., Kunkel, T. A., Wilson, S. H., & Levin, J. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19885 · Cited by 47
Nevirapine: A Review of its Use in the Prevention and Treatment of Paediatric HIV Infection
Bardsley-Elliot, A., & Perry, C. M. (2000) · Pediatric Drugs · doi:10.2165/00128072-200002050-00005 · Cited by 48
Competitive inhibitors of human immunodeficiency virus reverse transcriptase
Schinazi, R. F. (1993) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02171660 · Cited by 50
Borkow, G., Arion, D., Wainberg, M. A., & Parniak, M. A. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.259 · Cited by 50
“NNRTIs act by binding to a site on RT distinct from the catalytic site (14, 23, 37).”
BackgroundColacino, J. M., & Staschke, K. A. (1998) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8833-2_6 · Cited by 45
Schauer, G. D., Huber, K. D., Leuba, S. H., & Sluis‐Cremer, N. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku819 · Cited by 47
“In addition, NNTRIs force the p66 thumb into an open, extended position, which led to the hypothesis that NNRTIs induce ‘molecular arthritis’, whereby the relative domain movements in RT, thought to be necessary for the catalytic cycle of the enzyme, are inhibited (3).”
Chon, H., Matsumura, H., Koga, Y., Takano, K., & Kanaya, S. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.017 · Cited by 48
Synthesis and HIV-1 inhibition of novel benzimidazole derivatives
Gardiner, J. M., Loyns, C. R., Burke, A., Khan, A., & Mahmood, N. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00203-6 · Cited by 46
Defining a Molecular Mechanism of Synergy between Nucleoside and Nonnucleoside AIDS Drugs
Basavapathruni, A., Bailey, C. M., & Anderson, K. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300523200 · Cited by 46
Unge, T., Knight, S. D., Bhikhabhai, R., Lövgren, S., Dauter, Z., Wilson, K. S., & Strandberg, B. (1994) · Structure · doi:10.1016/s0969-2126(94)00097-2 · Cited by 51
Rieger, A., & Nassal, M. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.19.3909 · Cited by 49
Eitsuka, T., Nakagawa, K., Suzuki, T., & Miyazawa, T. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.08.017 · Cited by 47
Hermann, T., Meier, T., Götte, M., & Heumann, H. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4625 · Cited by 52
Acidic Residues Critical for the Activity and Biological Function of Yeast DNA Polymerase η
Kondratick, C. M., Washington, M. T., Prakash, S., & Prakash, L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2018-2025.2001 · Cited by 46
“All polymerases contain an invariant aspartate in motif A, as well as in motif C, and another highly conserved aspartate or glutamate is present in motif C of DNA polymerases but not in DNA-dependent RNA polymerases (Fig. 8). Although in various DNA polymerases, these three acidic residues are in optimal geometric pos…”
BackgroundLin, J. H., & Levin, H. L. (1997) · Genes & Development · doi:10.1101/gad.11.2.270 · Cited by 46
The role of nevirapine in the treatment of HIV-1 disease
Fumero, E., & Podzamczer, D. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.12.2065 · Cited by 44
“Nevirapine binds to a hydrophobic region of the RT p66 subunit between the Tyr181 and Tyr188 residues, which is located near the catalytic amino acid residues [2-6].”
BackgroundZhang, Z., Walker, M. P., Xu, W. F., Shim, J. H., Girardet, J., Hamatake, R. K., & Hong, Z. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00127-06 · Cited by 45
“NNRTIs bind to a unique hydrophobic pocket located near the palm subdomain of HIV-1 RT, which interferes with cooperative movements between the finger and thumb subdomains, thereby inhibiting catalysis of the enzyme (16, 19, 22, 26).”
BackgroundSzczepanowska, K., & Foury, F. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq267 · Cited by 49
“The catalytic reaction takes place in the palm subdomain at the bottom of the cleft (4).”
BackgroundStructural Folds of Viral Proteins
Chapman, M. S., & Liljas, L. (2003) · Advances in protein chemistry · doi:10.1016/s0065-3233(03)01004-0 · Cited by 50
Geitmann, M., Unge, T., & Danielson, U. H. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0504050 · Cited by 51
Zhang, H., Vrang, L., Bäckbro, K., Lind, P., Sahlberg, C., Unge, T., & Öberg, B. F. (1995) · Antiviral Research · doi:10.1016/0166-3542(95)00056-9 · Cited by 45
Accuracy, lesion bypass, strand displacement and translocation by DNA polymerases
Steitz, T. A., & Yin, Y. W. (2004) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2003.1374 · Cited by 44
“…B family and lesion bypass polymerases, as well as reverse transcriptase, all exhibit a palm domain structure that was first seen in the Klenow fragment of DNA polymerase I (Ollis et al. 1985a; Kohlstaedt et al. 1992; Wang et al. 1997; Doublié et al. 1998; Li et al. 1998b; Zhou et al. 2001).”
BackgroundSelf-citation
Metadata
- Authors
- Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Science
- Published
- 1992-06-26
- Volume
- 256
- Issue
- 5065
- Pages
- 1783-1790
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2008954911
- Cited by
- 1,914
- References
- 67
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 13 · 2023: 16 · 2022: 22 · 2021: 29 · 2020: 18 · 2019: 24 · 2018: 37 · 2017: 39 · 2016: 39 · 2015: 38 · 2014: 44 · 2013: 63 · 2012: 42
- FWCI
- 128.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01gm039546-10)
- National Institute of General Medical Sciences (GM 39546)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- HIV-1 reverse transcriptase, nevirapine, drug resistance, polymerase domain, asymmetric dimer, RNase H, RNA-DNA hybrids, active site, protein-inhibitor complex
- MeSH terms
- Azepines, Binding Sites, Crystallography, DNA Polymerase I, Escherichia coli, Models, Molecular, Protein Conformation, Pyridines, RNA-Directed DNA Polymerase, Molecular Structure, HIV-1, Nevirapine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.